In the realm of diabetes management, two innovative medications have emerged as frontrunners: tirzepatide and semaglutide. Both medications act on unique receptors within the body to manage blood sugar levels, offering promising outcomes for individuals with type 2 diabetes. However, these medications exhibit marked differences in their mechanisms

In the realm of diabetes management, two innovative medications have emerged as frontrunners: tirzepatide and semaglutide. Both medications act on unique receptors within the body to control blood sugar levels, offering promising results for individuals with type 2 diabetes. However, these medications exhibit marked differences in their mechanisms